ClinicalTrials.Veeva

Menu

A Cohort Study of Congenital Cytomegalovirus Infection Among Pregnant Women and Their Newborns in China

J

Jun Zhang

Status

Completed

Conditions

Congenital Cytomegalovirus Infection
Cytomegalovirus Infection Reactivation

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT02645396
CMV-EPI-001

Details and patient eligibility

About

The purpose of this study is to assess the risk of congenital cytomegalovirus (cCMV) infection in newborns born to seropositive women.

Full description

This study will be conducted at several Maternal and Child Health Hospitals (MCHHs) in China and the research activities will be integrated with routine medical services during pregnancy at the study sites.The investigators will build a perspective cohort study enrolling ~8000 pregnant women elder than 18 and following up their newborns at specific MCHHs.As a first step, The investigators will work with these hospitals to recruit the subjects. After being informed, the participants' remaining blood and urine samples (after their medical examinations) at their early, medium and late stages of pregnancy will be collected , and their newborns' urine and saliva samples will be collected after delivery. The aim of this study is to enroll 5000 series mother-newborns.

Enrollment

8,855 patients

Sex

Female

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Females aged 18 and older
  • Pregnancy confirmed by ultrasound
  • Come to MCHHs for "Pregnancy Registry" within 24 weeks of pregnancy

Exclusion criteria

  • Not capable of complying with study procedures, or having a psychosis, two-stage affective psychosis, or have a tendency to suicide
  • Having any autoimmune diseases (include systemic lupus erythematosus, rheumatoid arthritis), immunodeficiency (e.g. AIDS), chronic disease history such as cancers

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems